Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7560551 Aurora kinase modulators and method of use

Patent 7560551 was granted and assigned to Amgen on July, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Amgen

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

75605510

Patent Inventor Names

Victor J. Cee0

Hanh Nho Nguyen0

Karina Romero0

Date of Patent

July 14, 2009

Patent Application Number

116556420

Date Filed

January 18, 2007

Patent Citations Received

‌

US Patent 12102625 Solid forms of FXR agonists

‌

US Patent 11760728 Tead inhibitors and uses thereof

‌

US Patent 11833150 Methods of treating liver disease

‌

US Patent 11925651 TEAD inhibitors and uses thereof

‌

US Patent 11964961 Heteroaromatic compounds and their use as dopamine D1 ligands

Patent Primary Examiner

‌

Venkataraman Balasubramanian

Patent abstract

The present invention relates to chemical compounds having a general formula I

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7560551 Aurora kinase modulators and method of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API